Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
13.02.25
/
50%
€132.80
Target price
13.02.26
€234.78
Performance (%)
23.00%
Price
17:54
€163.35
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 23.00%. This prediction currently runs until 13.02.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 2.482% | 2.482% |
| iShares Core DAX® | 1.301% | -1.386% |
| iShares Nasdaq 100 | 0.612% | -4.172% |
| iShares Nikkei 225® | 8.772% | 9.777% |
| iShares S&P 500 | 0.254% | -2.301% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $281.00 to $245.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat